INNOCAN PHARMA Corp
INNPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $42,804 | $75,176 | $52,168 | $139,845 |
| - Cash | $5,008 | $3,885 | $4,947 | $11,048 |
| + Debt | $10 | $33 | $34 | $1 |
| Enterprise Value | $37,806 | $71,324 | $47,255 | $128,798 |
| Revenue | $29,437 | $13,657 | $2,559 | $196 |
| % Growth | 115.5% | 433.7% | 1,205.6% | – |
| Gross Profit | $26,187 | $11,978 | $2,107 | $121 |
| % Margin | 89% | 87.7% | 82.3% | 61.7% |
| EBITDA | -$1,212 | -$3,770 | -$3,698 | -$7,372 |
| % Margin | -4.1% | -27.6% | -144.5% | -3,761% |
| Net Income | -$1,834 | -$4,700 | -$3,764 | -$10,047 |
| % Margin | -6.2% | -34.4% | -147.1% | -5,126% |
| EPS Diluted | -0.42 | -1.19 | -0.982 | -2.906 |
| % Growth | 64.7% | -21.2% | 66.2% | – |
| Operating Cash Flow | -$1,579 | -$3,904 | -$6,067 | -$6,629 |
| Capital Expenditures | -$15 | -$46 | -$26 | -$41 |
| Free Cash Flow | -$1,594 | -$3,950 | -$6,093 | -$6,670 |